The Emerging Role of Interleukin-32 in HIV-Associated Cardiovascular C
|
The pathogenesis may involve several factors: HIV-related
proteins exacerbating endothelial injury and inflammation; immune activation
and chronic ... |
Rwanda: Six-Month HIV Prevention Injection Set for Rollout By Year-End
The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the year, according to ... View article...